Inovio Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
INO Inovio Pharmaceuticals Inc
SOL ReneSola Ltd
RYB RYB Education Inc
BAC Bank of America Corp
RETA Reata Pharmaceuticals Inc
RDFN Redfin Corp
RCUS Arcus Biosciences Inc
RBWNY Koninklijke Boskalis Westminster NV
RBII Rising Biosciences Inc
RAD Rite Aid Corp
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Inovio Pharmaceuticals, Inc. (Inovio) is a late-stage biotechnology company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), Ebola, Middle East Respiratory Syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, it has a pipeline of pre-clinical and clinical stage products that have generated in vivo immune responses.

Closing Price
$14.75
Day's Change
1.40 (10.49%)
Bid
--
Ask
--
B/A Size
--
Day's High
14.92
Day's Low
13.33
Volume
(Light)
Volume:
19,359,600

10-day average volume:
29,835,458
19,359,600
  • Prev Close
    13.35
  • Today's Open
    13.55
  • Day's Range
    13.33-14.92
  • Avg Vol (10-day)
    29.8M
  • Last (time)
    3:59p ET 05/29/20
  • Last (size)
    2
  • 52-Wk Range
    1.92 - 19.36
    LowHigh
  • (10/02/19 - 03/09/20)
    23.81%
  • 144.5%
  • Market Cap
    2.3B
  • Shares Outstanding
    158.1M
  • -1.17
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.4
  • 26.03
  • (% of float 05/15/20)
    14.87

Latest News

May 27, 2020
9:31 am ET
PR Newswire
May 26, 2020
5:38 pm ET
BusinessWire
8:00 am ET
PR Newswire
May 21, 2020
7:20 am ET
MarketWatch
May 20, 2020
11:51 am ET
Globe Newswire
9:31 am ET
PR Newswire
9:16 am ET
PR Newswire
7:31 am ET
MarketWatch
7:00 am ET
PR Newswire
May 18, 2020
2:05 pm ET
MarketWatch
May 16, 2020
12:02 pm ET
MarketWatch
May 14, 2020
7:00 am ET
PR Newswire
May 13, 2020
9:31 am ET
PR Newswire
May 12, 2020
10:50 am ET
Accesswire
10:50 am ET
Newsfile
9:10 am ET
Accesswire
8:50 am ET
PR Newswire
8:00 am ET
PR Newswire
2:05 am ET
Globe Newswire
May 11, 2020
10:50 pm ET
PR Newswire
7:43 pm ET
Accesswire
4:26 pm ET
Newsfile
1:08 pm ET
Globe Newswire
12:30 pm ET
Accesswire
10:46 am ET
Globe Newswire
10:40 am ET
Accesswire
9:31 am ET
PR Newswire
May 09, 2020
12:15 pm ET
Newsfile
11:10 am ET
Globe Newswire
May 08, 2020
10:50 pm ET
BusinessWire
3:01 pm ET
Accesswire
10:46 am ET
Accesswire
10:14 am ET
Newsfile
9:49 am ET
Newsfile
May 07, 2020
1:00 pm ET
Accesswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.